Empirical Antibiotic Therapy for Human Bite Wounds
Introduction to Antibiotic Selection
- The Infectious Diseases Society of America (IDSA) recommends amoxicillin-clavulanate 875/125 mg orally twice daily as the first-line empirical antibiotic for human bite wounds, with a strong recommendation and moderate quality evidence 1, 2, 3.
- This combination provides comprehensive coverage against both aerobic and anaerobic oral flora, including Eikenella corrodens, staphylococci, streptococci, and anaerobes 1, 2, 3.
Rationale for Specific Antibiotic Choices
- Eikenella corrodens is resistant to first-generation cephalosporins, macrolides, clindamycin, and aminoglycosides, making amoxicillin-clavulanate a better choice 1, 4, 5.
- Amoxicillin-clavulanate is effective against E. corrodens, staphylococci, streptococci, and anaerobes, making it a suitable option for human bite wounds 1, 2, 3.
Alternative Regimens
- For penicillin-allergic patients, doxycycline 100 mg orally twice daily is a preferred alternative, with good activity against Eikenella species, staphylococci, and anaerobes 1, 2, 3.
- Moxifloxacin 400 mg orally daily provides monotherapy coverage, including anaerobes 1, 3.
- A fluoroquinolone (ciprofloxacin 500-750 mg twice daily or levofloxacin 750 mg daily) plus metronidazole 500 mg three times daily can be used as an alternative regimen 1, 3.
Severe Infections Requiring IV Therapy
- For severe infections, ampicillin-sulbactam 1.5-3.0 g IV every 6 hours is recommended 1, 2, 3.
- Carbapenems (ertapenem, imipenem, or meropenem) are also effective for severe infections 1, 2, 3.
Important Clinical Caveats
- Clindamycin monotherapy should be avoided due to its inability to cover Eikenella corrodens 1, 3, 5.
- First-generation cephalosporins (cephalexin, cefazolin) should be avoided as they miss E. corrodens and anaerobes 4, 5.
- Trimethoprim-sulfamethoxazole or metronidazole alone should be avoided due to inadequate coverage 1, 3, 5.
Duration of Therapy and Additional Considerations
- Treatment duration should be 7-10 days for established infection 5.
- For prophylaxis in high-risk wounds, 3-5 days of preemptive therapy is recommended 2.
- Tetanus prophylaxis should be administered if the patient has not received tetanus toxoid within 10 years 1.
- Wound cultures should be obtained if the infection is severe, not responding to initial therapy, or the patient is immunocompromised 1.
- The combination of amoxicillin-clavulanate misses MRSA, so additional coverage may be needed if there is concern for MRSA involvement 1, 2, 3.